On August 28, 2019 Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, is reported at the 2019 Wells Fargo Healthcare Conference at the Westin Copley Place in Boston, Mass., on Wednesday, Sept. 4, 2019 (Press release, Edwards Lifesciences, AUG 28, 2019, View Source [SID1234539086]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Michael A. Mussallem, chairman and chief executive officer, and Scott B. Ullem, chief financial officer, are scheduled to speak to conference attendees at 9:05 a.m. ET. A live webcast of the presentation will be available to all interested parties on the Edwards Lifesciences investor relations website at View Source An archived version of the webcast will be available later that day on the Edwards investor relations website in the News and Events section and via the Edwards Lifesciences Investor Relations App for mobile devices.